XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income (loss) $ 5,047 $ (3,967)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 20,275 18,031
Amortization of deferred financing costs 680 260
Credit loss expense 45 31
Deferred income tax benefit (2,045) (590)
Equity-based employee and director compensation expense 732 368
Loss on dispositions and lease terminations, net 244 648
Changes in operating assets and liabilities, net of acquisitions 3,410 2,887
Net cash provided by operating activities 28,388 17,668
Cash flows from investing activities:    
Principal payments received on notes receivable 33 47
Proceeds from sale of assets 1,460 931
Capital expenditures (8,934) (10,621)
Cash paid in connection with acquisitions, net of cash acquired (1,885)  
Net cash used in investing activities (9,326) (9,643)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 30,600 34,500
Repayments on revolving credit facilities (26,575) (21,539)
Borrowings under the Term Loan Facility 1,120  
Repayments on the Term Loan Facility (24,600)  
Net proceeds from issuance of preferred membership interests 24,500  
Payments of finance lease obligations (658) (633)
Payments of deferred financing costs (6)  
Distributions paid on distribution equivalent rights (46) (31)
Distributions paid on common units (19,896) (19,881)
Net cash provided used in financing activities (15,561) (7,584)
Net increase in cash and cash equivalents 3,501 441
Cash and cash equivalents at beginning of period 7,648 513
Cash and cash equivalents at end of period $ 11,149 $ 954